Provided by Tiger Fintech (Singapore) Pte. Ltd.

LISATA THERAPEUTICS INC

2.70
+0.07002.66%
Post-market: 2.65-0.0500-1.85%17:20 EDT
Volume:494.20K
Turnover:1.36M
Market Cap:23.22M
PE:-1.18
High:3.09
Open:2.53
Low:2.49
Close:2.63
Loading ...

Lisata Therapeutics Is Maintained at Buy by Brookline Capital

Dow Jones
·
Yesterday

Lisata Therapeutics Inc - Patent Covers Certepetide's Structure and Applications

THOMSON REUTERS
·
Yesterday

H.C. Wainwright Keeps Their Buy Rating on Lisata Therapeutics (LSTA)

TIPRANKS
·
03 Jul

Lisata Therapeutics Announces Promising Preliminary Results from ASCEND Phase 2b Trial for Certepetide in Metastatic Pancreatic Cancer

Reuters
·
26 Jun

Positive Preliminary Cohort B Results From the Agitg-Led Ascend Trial to Be Presented at Esmo Gi Evaluating Lisata’s Certepetide in Combination With Standard-of-Care Chemotherapy in Metastatic Pancreatic Cancer

THOMSON REUTERS
·
26 Jun

Lisata Therapeutics - 6Mpfs of 60.8% for Certepetide-Treated Group VS 25% for Placebo in Data From Cohort B

THOMSON REUTERS
·
26 Jun

Lisata Therapeutics Inc - Full Study Data From Both Cohorts Expected Later This Year

THOMSON REUTERS
·
26 Jun

Lisata Therapeutics Inc - Cohort B Data Corroborate Cohort a Data for Certepetide

THOMSON REUTERS
·
26 Jun

Lisata, GATC announces strategic alliance to advance AI-driven drug discovery

TIPRANKS
·
17 Jun

Lisata Therapeutics to Advance AI-Discovered Opioid Use Disorder Therapeutic into Human Clinical Trials by Early 2026

Reuters
·
17 Jun

Lisata Therapeutics Inc. Announces Revised Compensation Agreements for Key Executives, Increasing Base Salaries and Clarifying Terms

Reuters
·
14 Jun

Lisata Therapeutics Inc. to Present at 2025 BIO International Convention in Boston

Reuters
·
11 Jun

Lisata Therapeutics Inc. Concluded Annual Stockholders Meeting with Key Proposals Approved

Reuters
·
11 Jun

Lisata Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
09 May

Lisata Therapeutics Q1 EPS $(0.55) Misses $(0.53) Estimate

Benzinga
·
09 May

Lisata Therapeutics Inc: Cash Runway Extending Into Q3 of 2026 With No Debt

THOMSON REUTERS
·
09 May

Lisata Therapeutics Inc expected to post a loss of 53 cents a share - Earnings Preview

Reuters
·
07 May

Lisata Therapeutics to Report First Quarter 2025 Financial Results and Provide a Business Update on Thursday, May 8, 2025

THOMSON REUTERS
·
01 May

Lisata Therapeutics to Report First Quarter 2025 Financial Results and Provide a Business Update on Thursday, May 8, 2025

GlobeNewswire
·
01 May

Will Lisata Therapeutics (NASDAQ:LSTA) Spend Its Cash Wisely?

Simply Wall St.
·
26 Apr